This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.


May 23, 2024
This retrospective study used KROK registry data from Poland between 2012 and 2022 to examine six-year survival after treatment for atrial fibrillation (AF), comparing no treatment, surgical ablation (SA), left atrial appendage occlusion (LAAO), or SA plus LAAO. 33,949 patients were included in the final analysis.
May 16, 2024
In this clinical video, the authors demonstrate a modified convergent procedure for refractory atrial fibrillation using 3D epicardial voltage mapping and left atrial appendage closure.
May 2, 2024
In a national analysis of 19,524 patients with preoperative atrial fibrillation undergoing isolated coronary bypass grafting surgery (11,508 patients [58.9 percent]), left atrial appendage closure (4541 patients [23.3 percent]), or with concomitant ablation and left atrial appendage closure (3475 patients [17.8 percent]), concomitant left atrial appe
May 1, 2024
The Cox-Maze procedure is an effective and successful method of surgical ablation. However, for lone atrial fibrillation cases, invasive sternotomy is not feasible. Patients with persistent atrial fibrillation can benefit by combining left atrial endocardial and epicardial interventions. A step-by-step approach of this hybrid totally thoracoscopic maze procedure is demonstrated in this video.
March 11, 2024
This video highlights robotic assistance in implanting epicardial pacemaker leads, showcasing successful outcomes in first-time and redo scenarios.
March 1, 2024
CTSNet Editor in Chief Joel Dunning spoke with Dr. Patrick Myers, CTSNet President and EACTS Secretary General, about the EACTS and STS joint session on cardiac trials that surgeons need to know about.
February 26, 2024
In this video, the authors present their technique for minimally invasive atrial fibrillation hybrid ablation of long persistent atrial fibrillation with concomitant thoracoscopic left atrial appendage closure.
January 23, 2024
Interesting conclusion on superiority of CRT over ICD
August 17, 2023
This paper reports the first in-human trial exploring surgical reduction therapy for hypertrophic obstructive cardiomyopathy (HOCM). Patients recruited to the trial were those who presented with refractory HOCM with disabling symptoms despite best medical management.
April 5, 2022
A brief but comprehensive editorial on nuances of the links between atrial fibrillation and heart failure, apropos a trial we have commented recently on, by the Johns Hopkins team that develops the calmodulin-dependent protein kinase II inhibitor molecules